Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
13.25
0.74 (5.92%)
At close: Sep 05, 2025, 3:59 PM
13.01
-1.83%
After-hours: Sep 05, 2025, 05:16 PM EDT
5.92% (1D)
| Bid | 12.31 |
| Market Cap | 27.12M |
| Revenue (ttm) | 2.13K |
| Net Income (ttm) | -10.44M |
| EPS (ttm) | -8.88 |
| PE Ratio (ttm) | -1.49 |
| Forward PE | -2.37 |
| Analyst | Buy |
| Ask | 13.5 |
| Volume | 36,930 |
| Avg. Volume (20D) | 30,420 |
| Open | 12.50 |
| Previous Close | 12.51 |
| Day's Range | 12.50 - 13.40 |
| 52-Week Range | 6.89 - 22.90 |
| Beta | 0.95 |
About CVKD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CVKD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CVKD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+23.72%
Cadrenal Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
10 months ago
+17.97%
Cadrenal Therapeutics shares are trading higher after the company announced that is has raised gross proceeds of approximately $5.1 million through its at-the-market facility.
